GERMANY – The German Packaging Institute has honored Syntegon, formerly Bosch Packaging Technology, with the German Packaging Award for the development of its Versynta microBatch.
The fully automated and highly flexible production cell is designed to fill and close a variety of containers with pharmaceutical liquids and enables a complete batch-to-batch changeover of less than two hours.
Syringes, cartridges, and vials made of glass or plastic can be filled with virtually no product loss.
The gloveless isolator with integrated air treatment significantly reduces the risk of contamination since it eliminates manual intervention.
Fully automated filling and 100 percent in-process control ensure continuously high quality. Versynta microBatch is an innovative, GMP-compliant system that sets new standards in small batch filling with an output of 120 to 500 containers per hour.
Following the TPU1000 paper forming machine for sustainable food portion packs in 2020 and the paper alternative “Blister meets Paper” for tablet packaging last year, Syntegon now receives the third German Packaging Award in a row.
Versynta microBatch has also been honored before: in October 2021, the Parental Drug Association (PDA) presented Syntegon and its development partner Vetter, an international pharmaceutical service provider for injectable drugs, with the PDA Drug Delivery Innovation Award in the “Partnership Innovation” category.
Moreover, the Versynta FFP (Flexible Filling Platform) was also on show. With this new, modular platform, Syntegon offers an individually configurable machine for aseptic small batch filling with an output of up to 3,600 containers per hour.
Every year, the German Packaging Institute honors groundbreaking packaging ideas and machines in a contest that encompasses all industries and packaging materials.
Meanwhile, Syntegon Group intends to appoint Peter Hackel as member of the executive board at the beginning of 2023.
In his new position, as chief financial officer, Hackel will be responsible for Finance & Controlling, Foreign Trade, and IT of Syntegon. He will be located at Beringen, Switzerland.
Hackel is a well-rounded, highly accomplished executive, experienced in sales as well as in finance, and in this capacity has served as chief financial officer in different companies for more than nine years.
He started his career with McKinsey & Company Inc. followed by Geistlich Pharma AG, Oerlikon Corporation AG.
His most recent job stint was at Straumann Holding AG, where he has contributed to the positive development of the company as group chief financial officer and member of the group executive management board since 2014.
He holds a Ph.D. degree in molecular biology from the Swiss Federal Institute of Technology (ETH) in Zurich, Switzerland, and studied business administration at the University of Hagen, Germany.
Liked this article? Sign up to receive our regular email newsletters, focused on Africa and World’s healthcare industry, directly into your inbox. SUBSCRIBE HERE
